Table 1. Baseline characteristics of patients.
| Variables | MHR | P | ||
|---|---|---|---|---|
| Tertile 1 (n=1923) | Tertile 2 (n=1880) | Tertile 3 (n=1876) | ||
| Age (years) | 60.41 ± 10.34 | 59.64 ± 10.78 | 58.36 ± 11.14 | <0.001 |
| Gender (male) | 1277 (66.4%) | 1422 (75.6%) | 1523 (81.2%) | <0.001 |
| Smoking | 637 (35%) | 756 (40.2%) | 852 (45.4%) | <0.001 |
| Hypertension | 818 (42.5%) | 793 (42.2%) | 814 (43.4%) | 0.743 |
| SBP | 127.65 ± 18.98 | 127.13 ± 18.93 | 126.42 ± 18.35 | 0.126 |
| DBP | 76.28 ± 11.30 | 76.05 ± 11.25 | 76.57 ± 11.41 | 0.381 |
| Diabetes mellitus | 455 (23.7%) | 481 (25.6%) | 452 (24.1%) | 0.352 |
| Hyperlipidemia | 163 (8.5%) | 162 (8.7%) | 174 (9.3%) | 0.647 |
| BUN | 5.43 ± 1.58 | 5.51 ± 1.66 | 5.62 ± 1.76 | 0.003 |
| Cr | 73.25 ± 19.36 | 76.29 ± 20.58 | 78.43 ± 20.02 | <0.001 |
| UA | 315.18 ± 86.55 | 325.95 ± 89.60 | 328.61 ± 94.12 | <0.001 |
| Blood glucose | 6.59 ± 3.21 | 6.57 ±3.17 | 6.70 ± 3.90 | 0.453 |
| TG | 1.73 ± 1.19 | 1.90 ± 1.21 | 2.07 ± 1.37 | <0.001 |
| TC | 4.09 ± 1.13 | 3.98 ± 1.10 | 3.80 ± 107 | <0.001 |
| HDL | 1.25 ± 0.71 | 0.98 ± 0.21 | 0.82 ± 0.21 | <0.001 |
| LDL | 2.55 ± 0.95 | 2.47 ± 0.89 | 2.36 ± 0.89 | <0.001 |
| Apo-A1 | 1.26 ± 0.35 | 1.16 ± 0.28 | 1.08 ± 0.29 | <0.001 |
| Apo-B | 0.86 ± 0.39 | 0.85 ± 0.39 | 0.84 ± 0.41 | 0.22 |
| Lp(a) | 219.65 ± 177.99 | 215.62 ± 168.88 | 225.67 ± 183.16 | 0.215 |
| CCB (n,%) | 226 (11.8) | 210 (11.2) | 207(11.1) | 0.734 |
| β-Blockers (n,%) | 799 (41.8) | 727 (38.8) | 775 (41.5) | 0.125 |
| ARB (n,%) | 448 (23.5) | 433(23.2) | 410(21.9) | 0.488 |
| Statin (n,%) | 1072 (56.3) | 992 (53.2) | 984(52.9) | 0.065 |
Abbreviations: ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; BUN, blood urea nitrogen; Cr, creatinine; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; Lp(a), lipoprotein a; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; UA, uric acid.